The company
Silo Pharma, Inc.
SILO · Nasdaq
SILO stood above a rising 150-day average in 0 of the last 52 weekly readings. It is 75.6% below that average now. Biotechnology: 16% of its 561 stocks in an uptrend (−15 points in four weeks); Health Care: 26% (−10 points in four weeks).
Statistics
- Rotation
- Not moving yet
- Weeks in an uptrend
- out for 52
- Industry in uptrend
- 16% -15 in 4 wk
- Insider buys, 12 months
- $7,660
- Insider sales, 12 months
- $0
- Officials’ trades on record
- 0
- Institutions holding
- 7 (-7)
In the rotation
Each square a week: lit when it closed above a rising 150-day average. 0 of 52 weeks.
Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.
Money in and out
Open-market buys above the line and sales below, in dollars.
Congress and officials
No member of Congress or official has disclosed a trade in it.
Insiders
No open-market buy or sale by its insiders on record.
Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.
Institutions
Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.
| Manager | Shares | Change |
|---|---|---|
| AdvisorShares Investments LLCreduced · filed 11 Aug 2026 | 75,582$469K | -588,383−88.6% |
| CITADEL ADVISORS LLCreduced · filed 14 Aug 2026 | 16,800$104K | -4,648−21.7% |
| VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 2026 | 11,956$74K | +735+6.6% |
| VANGUARD FIDUCIARY TRUST COreduced · filed 13 Aug 2026 | 874$5,428 | -12,226−93.3% |
| Tower Research Capital LLC (TRC)reduced · filed 11 Aug 2026 | 181$1,124 | -1,496−89.2% |
| HARBOUR INVESTMENTS, INC.new · filed 12 Aug 2026 | 14$87 | +14 |
News
Everyone who traded it
Same industry
Government contracts
No federal award is tied to it.
From its SEC filings
Analyst forecasts
No analyst forecasts yet.